Tag: Indian Pharma

India’s NPPA Reduced of Anti-Cancer Drugs’ Prices by 87%

In a big relief to cancer patients and their families, the retail prices of nine anti-cancer drugs have been reduced by up to 87 per cent by the National Pharmaceutical Pricing Authority (NPPA).  T...

Indian Pharma Representatives Deny Allegations of Price Fixing in US

Indian pharma majors Dr Reddy's, Workhardt, Aurobindo and Glenmark, which are among the generic drug makers named in an anti-trust lawsuit in the US, May 14 denied allegations of engaging in conspirac...

Indian Pharma Company Invested in Belarusian Manufacturing Project

Indian pharmaceutical company Cipla Limited has invested $1 million in the pharmaceutical manufacturing project in Minsk. The project was discussed by Chairman of the Presidium of the National Academy...

Indian Pharma Exports Registered a Double-Digit Growth

Indian pharma exports hit $19.14 billion. Last time it registered a double-digit growth of 10.17 per cent at $16.89 billion in 2015-16. Pharmaceutical Export Promotion Council (Pharmexcil)'s year-end...

India Rejects U.S. Medicines Report

counterfeit drug
India has outrightly rejected allegations in a US report about the country being a chief source of counterfeit medicines to the world and said it is an attack on low cost generic-drugs — crucial to ma...

India’s Pharmaceutical Exports rose 11% to $19.2 billion

india pharma
The country’s pharmaceutical exports rose 11 per cent to $19.2 billion in 2018-19, mainly driven by higher demand in regions such as North America and Europe, as per a Commerce Ministry data. The p...

Local Indian Pharma Companies to Challenge MNCs in Pneumonia Vaccine

The duopoly of pneumonia vaccines in India is in for some shake-up soon, as homegrown players like Aurobindo Pharma, Cadila Healthcare (Zydus Cadila), and Serum Institute are readying their vaccin...

Pharma Products Turn to Cold Chain Logistics

A cold chain is a temperature-controlled supply chain which is required to preserve and maintain perishable products like food items, chemicals and now, pharmaceutical products. It involves constant r...

India to Promote Clinical Research

The Health Ministry has recently notified New Drugs and Clinical Trials Rules, 2019, with a goal to promote clinical research in the nation, for lowering the time of application approval to 30 days fo...

FDA Approved Lupin’s Generic of Pfizer to Market

Pharma major Lupin announced that it has received approval for its Atorvastatin Calcium Tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg, from the United States Food and Drug Administration (FDA) to market...

Belarus-India Joint Facility Opened near Grodno

A Belarus-India joint venture was commissioned in Skidel near Grodno on 7 March. The new company, Novalok, was founded by Belmedpreparaty and Indian pharmaceutical company Lok-Beta Pharmaceuticals (I)...

Zydus Cadila Announced First Approval for Transdermal Product in US

Zydus Cadila has received the approval from the USFDA to market Rivastigmine Transdermal System (US RLD – EXELON® PATCH), 4.6 mg/24 hrs, 9.5 mg/24 hrs and 13.3 mg/24 hrs, marking its first approval fo...

Indian Drugs Are on High Demand in Russia

In Mumbai (India), the Russia-India Forum on Interaction between Small and Medium Enterprises was launched. The Forum is a platform for several round-table discussions on the topical issues of bilater...

Indian Company Collaborates with Sanofi in CNS Area

Jubilant Biosys, a Bengaluru-based subsidiary of Jubilant Life Sciences, announced a new integrated drug discovery collaboration with Sanofi in the CNS therapeutic area. The first collaboration with S...

Potential to Growth for Indian Pharma

The Pharmaceutical Export Promotion Council of India (Pharmexcil), Ministry of Commerce and Industry, has projected over 10 percent growth in pharma exports from India during this fiscal at or over $1...

India and Vietnam Have Potential Growth in Pharma Trade

Significant potential for growth in trade in pharmaceutical and healthcare products exists between India and Vietnam, experts at the Indian Pharmaceutical Exhibition and B2B Interaction said on Monday...